Barclays
MBIO icon

Barclays’s Mustang Bio MBIO Stock Holding History

Barclays’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$787 Buy
+1,121
New +$796 ﹤0.01% 4955
2023
Q4 		– Sell
-83
Closed -$8.56K – 5302
2023
Q3 		$8.56K Hold
83
– – ﹤0.01% 4326
2023
Q2 		$25.7K Buy
+83
New +$20.8K ﹤0.01% 4083
2022
Q4 		– Sell
-86
Closed -$30K – 5334
2022
Q3 		$30K Sell
86
-7
-8% -$3.24K ﹤0.01% 3941
2022
Q2 		$41K Sell
93
-16
-15% -$8.86K ﹤0.01% 4111
2022
Q1 		$83K Sell
109
-102
-48% -$83.8K ﹤0.01% 3867
2021
Q4 		$263K Buy
211
+91
+76% +$147K ﹤0.01% 3466
2021
Q3 		$242K Buy
120
+53
+79% +$114K ﹤0.01% 3524
2021
Q2 		$166K Sell
67
-44
-40% -$108K ﹤0.01% 3633
2021
Q1 		$277K Buy
111
+89
+405% +$265K ﹤0.01% 3548
2020
Q4 		$61K Buy
22
+5
+29% +$12K ﹤0.01% 4330
2020
Q3 		$41K Sell
17
-4
-19% -$9.86K ﹤0.01% 4688
2020
Q2 		$50K Buy
21
+9
+75% +$21K ﹤0.01% 4935
2020
Q1 		$25K Sell
12
-25
-68% -$64.1K ﹤0.01% 5567
2019
Q4 		$114K Buy
37
+19
+106% +$43.5K ﹤0.01% 5405
2019
Q3 		$45K Sell
18
-6
-25% -$16.4K ﹤0.01% 5959
2019
Q2 		$66K Buy
24
+18
+300% +$51.4K ﹤0.01% 5952
2019
Q1 		$16K Buy
+6
New +$17K ﹤0.01% 6428
2018
Q4 		– Sell
-8
Closed -$36K – 7153
2018
Q3 		$36K Buy
8
+6
+300% +$30K ﹤0.01% 6247
2018
Q2 		$8K Sell
2
-8
-80% -$50.5K ﹤0.01% 6614
2018
Q1 		$81K Buy
+10
New +$85.2K ﹤0.01% 5536

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CG
CFO4Life Group Coppell, Texas $743M AUM 25.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Barclays's MBIO Position: Q2 2026 in Review

Barclays opened a new position in Mustang Bio (MBIO) in Q2 2026: 1,121 shares worth $787. The stake represents ﹤0.01% of the portfolio and ranks #4955 among its holdings. This is a return to the name: Barclays previously reported a position in MBIO as recently as Q3 2023.

Barclays first reported a position in MBIO in Q1 2018 and has held it in 21 quarters since. The position peaked at $277K in Q1 2021. 23 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • Barclays held 1,121 shares of Mustang Bio worth $787 as of Q2 2026.
  • Mustang Bio was a new Barclays position in Q2 2026.
  • Mustang Bio made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4955 holding.
  • Barclays first reported a position in Mustang Bio in Q1 2018 and has held it in 21 quarters since.
  • Barclays's Mustang Bio position peaked at $277K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.